GlassScriptPhysician profile
Chad A Strittmatter
NPI 1184692816
$895.22
in general payments reported to CMS, 2019-2025
13 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.16 · 2021: $59.12 · 2022: $28.45 · 2023: $213 · 2024: $424 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $456 · Education: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $455.55 |
| Education | $289.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $289.94 | 2023-2024 | |
| Dexcom, INC. | $147.70 | 2024 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Meditrina | $74.00 | 2022-2024 | |
| Davol INC. | $72.36 | 2021-2024 | Arista Ah Flexitip |
| Hologic Sales and Service, LLC | $53.24 | 2025 | Fetal Fibronectin Enzyme Immunoassay, Thinprep 2000 Processor |
| Coopersurgical, INC. | $49.65 | 2021-2024 | Summit Doppler |
| Coloplast Corp | $45.91 | 2019 | |
| Abbvie INC. | $33.92 | 2019-2024 | |
| Exeltis, USA INC. | $31.33 | 2024 | Nuvessa |
| Biogen, INC. | $29.90 | 2025 | Zurzuvae |
| Medtronic, INC. | $24.71 | 2025 | Truclear |
| Exact Sciences Corporation | $23.40 | 2023 | Cologuard Collection Kit |
| Baudax Bio INC. | $19.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Strittmatter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.